KYTX SCHEDULE 13G/A: SEC filing

GordonMD Global Investments LP

Filed with the SEC on · accession 0000919574-26-008017

KYTX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -5.7% by the first close after the filing.

Summary of the filing

GordonMD Global Investments LP filed an amended Schedule 13G reporting beneficial ownership of 4,521,318 shares (7.34%) of Kyverna Therapeutics common stock as of September 30, 2026, a passive investment position.

Key details

Shares beneficially owned by GordonMD Global Investments LP$4.5M
Shares beneficially owned by GordonMD Long Biased Master Fund LP$4.2M
Filer / beneficial ownerGordonMD Global Investments LP
Advisory client holding 4,198,616 shares (6.79%)GordonMD Long Biased Master Fund LP
General partner of the master fundGordonMD Long Biased GP LLC
General partner of the filerGordonMD Global Investments GP LLC
IssuerKyverna Therapeutics, Inc.
Managing member of the general partner, gordonmd global investments lpCraig D. Gordon

How KYTX stock reacted

Close before

$5.05

Nov 13, 2026

First close after

-5.74%

$4.76

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for KYTX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for KYTX?

Click here

Frequently asked questions

What did KYTX file with the SEC on Nov 16, 2026?

KYTX filed a SCHEDULE 13G/A (SEC filing). GordonMD Global Investments LP filed an amended Schedule 13G reporting beneficial ownership of 4,521,318 shares (7.34%) of Kyverna Therapeutics common stock as of September 30, 2026, a passive investment position.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did KYTX stock react to this filing?

KYTX closed at $5.05 before the filing and $4.76 on Nov 16, 2026 (-5.74%).

Other KYTX SEC filings

Get alerts when KYTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days